Esperion Therapeutics
ESPR
#6131
Rank
NZ$1.56 B
Marketcap
NZ$6.61
Share price
1.06%
Change (1 day)
26.16%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -NZ$49.04 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.30 Billion. In 2024 the company made an earning of NZ$12.95 Million, an increase over its 2023 earnings that were of -NZ$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$49.04 Million-478.52%
2024 NZ$12.95 M-104.99%
2023 -NZ$0.26 Billion-15.03%
2022 -NZ$0.31 Billion-20.61%
2021 -NZ$0.39 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.35 Billion19.57%
2017 -NZ$0.3 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$85.02 Million36.45%
2014 -NZ$62.32 Million43.55%
2013 -NZ$43.41 Million145.26%
2012 -NZ$17.7 Million
2002 -NZ$50.46 Million-7.81%
2001 -NZ$54.74 Million15.03%
2000 -NZ$47.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-NZ$0.9 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.17 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.45 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.87 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.59 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA